Академический Документы
Профессиональный Документы
Культура Документы
Type 1 diabetes
-cell destruction
Type 2 diabetes
Progressive insulin secretory defect
Other specific types of diabetes
Genetic defects in -cell function, insulin action
Diseases of the exocrine pancreas
Drug- or chemical-induced
Gestational diabetes mellitus (GDM)
*For all three tests, risk is continuous, extending below the lower limit of a range and becoming disproportionately
greater at higher ends of the range.
Type 2 Disability
Normal IGT Complications
Diabetes Death
Preclinical Clinical
state disease Complications
10/15 (17) 27 -
15-19 16-17 23 -
20-29 12-14 16 -
30-39 10-11 11 -
40-49 8-9 10 7-8
50-59 6-7 6 5-6
60-69 4-5 5 3-4
70+ - - 3
infarction
50
Microvascular
40 disease
30
20
10
0
<6 6-<7 7-<8 8-<9 9-<10 10+
Updated HbA1c (%)
UKPDS 35, BMJ 2000; 321: 405-12
Chronic Complications in Newly Diagnose Diabetes Mellitus
50% of patients had 1 complications
Stroke or TIA: 1%
Retinopathy: 21%
NEWLY
DIABETES
Hypertension: 35%
Plasma creatinine
>120mol/l: 3%
Abnormal ECG : 18%
Intermittent
Claudicasio: 3%
Erectal Dysfuntion : 20%
Classify diabetes
Detect complication
Previous treatment and glycemic
control
Management plan
An integrated approach is needed
- 14%
Heart attacks
- 37%
Microvascular complications
1%
- 43%
Peripheral vascular disorders
*p<0.0001
UKPDS 35 BMJ 2000;321:405-412
17
Barriers and limitation to Goal
25
26
26
Targets for Glycemic (blood sugar)
Control In Most Non-Pregnant Adults
ADA AACE
A1c (%)
<7* 6.5
Fasting (preprandial) plasma
glucose 70-130 mg/dL <110 mg/dL
American Diabetes Association. Diabetes Care. 2011;34(suppl 1) *<6 for certain individuals
Implementation Conference for ACE Outpatient Diabetes Mellitus Consensus Conference Recommendations: Position Statement
at http://www.aace.com/pub/pdf/guidelines/OutpatientImplementationPositionStatement.pdf. Accessed January 6, 2006.
AACE Diabetes Guidelines 2002 Update. Endocr Pract. 2002;8(suppl 1):40-82.
27
28
29
30
31
31
32
34
35
36
37
38
39
40
41
42
UKPDS : Hasil dari Pengobatan Diabetes
tipe 2
3 tahun :
48-55% memiliki HbA1c<8%
41-46% memiliki HbA1c<7%
6 tahun :
35-38% memiliki HbA1c<8%
25-27% memiliki HbA1c<7%
9 tahun :
16-21% memiliki HbA1c<8%
10-18% memiliki HbA1c<7%
KESIMPULAN :
Sejalan dengan waktu pasien diabetes tipe 2 akan
memerlukan terapi insulin/kombinasi dengan insulin
Prof. Z.T Bloomgarden
11th AFES Congress, Bali, Nov 2001 43
44
45
46
47
48
49
Type 2 Diabetes Anti-Hyperglycemic Therapy:
General Recommendations
Healthy eating, weight control, increased physical activity
Initial Drug Monotherapy Metformin
Efficacy ( HbA1c) High
Hypoglycemia Low risk
Weight Neutral / loss
Side effects GI / lactic acidosis
Cost Low
Consider initial dual If needed to reach individualized HbA target after ~3 months, proceed to two-drug combination
Begin with
combination therapy these options if(order not meant to denote any specific preference):
1c
If combination therapy that includes basal insulin has failed to achieve HbA1c target after 3-6
More Complex months, proceed to a more complex
Insulin Strategies insulin strategy, usually in combination with one or two non-insulin agents
Insulin (multiple daily doses)
Diabetes Care 2012;35:1364-79.
Diabetologia 2012;55:1577-96.
Lesson from the recent guidelines
Single OAD:
Used as first line drug for A1C level 6.5-7.5%
First choice: Met, TZD,DPP IV, AGI (depend on clinical
presentation of patients)
SU ??
Combination OAD:
Used for first line for A1C level 7.6-9.0%
Metformin is always used for any combination with other
OAD
Triple drug combination still usage
Insulin:
Can be combined with OAD at any level of A1C if target A1C can not
achieved by OAD only
Used as first line drug in: drug naive patient with symptom of metabolic
decompensated or patient failure in OAD
52
THANK
YOU
Curiculum Vitae : dr. Andi Sulistyo H,
Sp.PD
Tempat/Tgl Lahir :Malang, 28 Mei 1978
Pendidikan :
1. S1 dan Dokter Fakultas Kedokteran Universitas Brawijaya Malang
2. Dokter Spesialis Penyakit Dalam, Fakultas Kedokteran Universitas
Brawijaya Malang
. Pengalaman Organisasi :
1. Sie Minat & Bakat Senat Mahasiswa Fakultas Kedokteran Universitas
Brawijaya Th 1996-1997
2. Pengurus PAPDI Cab. Malang ( Sie Informasi & Komunikasi ) Th 2012 -
Sekarang
. Pengalaman Bekerja :
1.Dokter Spesialis Penyakit Dalam Dinas Kesehatan Kota Malang 2003 2015
2. Dokter Spesialis Penyakit Dalam RSUD Kota Malang 2015 Sekarang
3. Dokter Spesialis Penyakit Dalam RSU Mitra Delima 2010 Sekarang
4. Dokter Spesialis Penyakit Dalam RSU Prasetya Husada Karangploso 2010 -
Sekarang